When was Sionna Therapeutics, Inc. stock made available for the first time to the public?

The IPO Date for Sionna Therapeutics, Inc. is 2025-02-07. On this 2025-02-07, Sionna Therapeutics, Inc. stock was made publicly available.

Where is the headquarters of Sionna Therapeutics, Inc. stock?

Headquarters of Sionna Therapeutics, Inc. is in US at 21 Hickory Drive Suite 500, Waltham, MA 02451.

What industry does Sionna Therapeutics, Inc. belong to?

The Sionna Therapeutics, Inc. belongs to Biotechnology.

Sionna Therapeutics, Inc.

SION•NASDAQ

Healthcare

Biotechnology

$17.35

$0.00(0.00%)

Sionna Therapeutics, Inc. (SION) Company Profile & Overview

Explore Sionna Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Sionna Therapeutics, Inc. (SION) Company Profile & Overview

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.

SectorHealthcare

IndustryBiotechnology

CEOMichael Cloonan

Contact Information

https://www.sionnatx.com

21 Hickory Drive Suite 500, Waltham, MA, 02451

Company Facts

41 Employees

IPO DateFeb 7, 2025

CountryUS

Actively Trading

Frequently Asked Questions

;